DNA Polymorphism of HLA Class II Genes in Primary Biliary Cirrhosis

Overview

Journal Immunogenetics

Specialties Allergy & Immunology
Genetics

Date 1992 Jan 1

PMID 1735557

Citations 7

Authors

N Morling

K Dalhoff

L Fugger

J Georgsen

B Jakobsen

L Ranek

N Odum

A Svejgaard

Affiliations

Soon will be listed here.

Abstract

We investigated the DNA restriction fragment length polymorphism of the major histocompatibility complex class II genes: HLA-DRB, -DQA, -DQB, DPA, -DPB, the serologically defined HLA-A, B, C, DR antigens, and the primed lymphocyte typing defined HLA-DP antigens in 23 Danish patients with primary biliary cirrhosis (PBC) and in healthy Danes. The following genetic markers were found with increased frequencies in PBC: HLA-B8 (relative risk, RR = 2.4, P less than 0.05, 'corrected' P greater than 0.05), HLA-DR3 (RR = 3.4, P less than 0.01, 'corrected' P less than 0.05), the DRB3*01/02/03 (DRw52) associated DRB Bgl II 9.1 kilobase (kb) fragment (RR = 2.9; P less than 0.05, 'corrected' P greater than 0.05), the DQA1*0501 associated DQA Taq I 4.8 kb fragment (RR = 3.1; P less than 0.05, 'corrected' P greater than 0.05), the DQB1*0201 (DQw2) associated DQB Hin dIII 11.5 kb fragment (RR = 3.1; P less than 0.05, 'corrected' P greater than 0.05). No DNA fragments specific for DRB1*0301 (DR3) could be identified. The frequencies in PBC of other genetic markers including DRw8, DRB1*08, HLA-DP antigens, DPA, and DPB genes did not differ significantly from those in controls. The associations between PBC and B8, DR3, DQA1*0501, and DQB1*0201, which are frequently found together on the same haplotype, are at variance with recent reports on associations between PBC and Drw8. The discrepancy suggests that PBC is genetically heterogenous.

Citing Articles

New insights on the role of human leukocyte antigen complex in primary biliary cholangitis.

Mulinacci G, Palermo A, Gerussi A, Asselta R, Gershwin M, Invernizzi P Front Immunol. 2022; 13:975115.

PMID: 36119102 PMC: 9471323. DOI: 10.3389/fimmu.2022.975115.

Distinctive HLA-II association with primary biliary cholangitis on the Island of Sardinia.

Clemente M, Frau F, Bernasconi M, Macis M, Cicotto L, Pilleri G United European Gastroenterol J. 2017; 5(4):527-531.

PMID: 28588884 PMC: 5446142. DOI: 10.1177/2050640616665030.

Association of human leukocyte antigen class II with susceptibility to primary biliary cirrhosis: a systematic review and meta-analysis.

Qin B, Wang J, Chen J, Liang Y, Yang Z, Zhong R PLoS One. 2013; 8(11):e79580.

PMID: 24265779 PMC: 3827176. DOI: 10.1371/journal.pone.0079580.

Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving.

Invernizzi P Hepatology. 2011; 54(2):714-23.

PMID: 21563204 PMC: 3145017. DOI: 10.1002/hep.24414.

Genomic variants associated with primary biliary cirrhosis.

Selmi C, Torok N, Affronti A, Gershwin M Genome Med. 2010; 2(1):5.

PMID: 20193050 PMC: 2829930. DOI: 10.1186/gm126.

References

Fugger L, Morling N, Ryder L, Platz P, Georgsen J, Jakobsen B . NcoI restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNF alpha) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol. 1989; 30(2):185-9. DOI: 10.1111/j.1365-3083.1989.tb01200.x. View

Bendtzen K, Morling N, Fomsgaard A, Svenson M, Jakobsen B, Odum N . Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol. 1988; 28(5):599-606. DOI: 10.1111/j.1365-3083.1988.tb01492.x. View

Bassendine M, Dewar P, James O . HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut. 1985; 26(6):625-8. PMC: 1432751. DOI: 10.1136/gut.26.6.625. View

Odum N, Hartzman R, Jakobsen B, Morling N, Platz P, ROBBINS F . The HLA-DP polymorphism in Denmark investigated by local and international PLT reagents. Definition of two "new" DP antigens. Tissue Antigens. 1986; 28(2):105-18. DOI: 10.1111/j.1399-0039.1986.tb00468.x. View

Fugger L, Morling N, Ryder L, Jakobsen B, Andersen V, Oxholm P . Restriction fragment length polymorphism of two HLA-B-associated transcripts genes in five autoimmune diseases. Hum Immunol. 1991; 30(1):27-31. DOI: 10.1016/0198-8859(91)90067-j. View

Fugger L, Bendtzen K, Morling N, Ryder L, Svejgaard A . Possible correlation of TNF alpha-production with -RFLP in humans. Eur J Haematol. 1989; 43(3):255-6. DOI: 10.1111/j.1600-0609.1989.tb00292.x. View

Ercilla G, Pares A, Arriaga F, Bruguera M, Castillo R, Rodes J . Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens. 1979; 14(5):449-52. DOI: 10.1111/j.1399-0039.1979.tb00874.x. View

Prochazka E, Terasaki P, Park M, Goldstein L, Busuttil R . Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med. 1990; 322(26):1842-4. DOI: 10.1056/NEJM199006283222603. View

Jakobsen B, Morling N, Platz P, Ryder L, Thomsen M, Svejgaard A . HLA-DR phenotype and HLA-B,DR haplotype frequencies in 704 unrelated Danes. Tissue Antigens. 1981; 18(4):270-5. DOI: 10.1111/j.1399-0039.1981.tb01391.x. View

10.

Morling N, Odum N, Ryder L, Platz P, Jakobsen B, Svejgaard A . Restriction fragment length polymorphism of the HLA-DP subregion and correlations to HLA-DP phenotypes. Proc Natl Acad Sci U S A. 1987; 84(6):1644-8. PMC: 304493. DOI: 10.1073/pnas.84.6.1644. View

11.

James S, Hoofnagle J, Strober W, Jones E . NIH conference: Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med. 1983; 99(4):500-12. DOI: 10.7326/0003-4819-99-4-500. View

12.

Johnston D, KAPLAN M, Miller K, Connors C, Milford E . Histocompatibility antigens in primary biliary cirrhosis. Am J Gastroenterol. 1987; 82(11):1127-9. View

13.

Babbitt B, Allen P, Matsueda G, Haber E, UNANUE E . Binding of immunogenic peptides to Ia histocompatibility molecules. Nature. 1985; 317(6035):359-61. DOI: 10.1038/317359a0. View

14.

Svejgaard A, Platz P, Ryder L . HLA and disease 1982--a survey. Immunol Rev. 1983; 70:193-218. DOI: 10.1111/j.1600-065x.1983.tb00715.x. View

15.

Gores G, Moore S, Fisher L, Powell F, Dickson E . Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens. Hepatology. 1987; 7(5):889-92. DOI: 10.1002/hep.1840070516. View

16.

Bidwell J, Bidwell E, Savage D, Middleton D, Klouda P, Bradley B . A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10. Transplantation. 1988; 45(3):640-6. DOI: 10.1097/00007890-198803000-00027. View

17.

Kaufman J, Auffray C, Korman A, Shackelford D, Strominger J . The class II molecules of the human and murine major histocompatibility complex. Cell. 1984; 36(1):1-13. DOI: 10.1016/0092-8674(84)90068-0. View

18.

Miyamori H, Kato Y, Kobayashi K, Hattori N . HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion. 1983; 26(4):213-7. DOI: 10.1159/000198892. View

19.

Ragoussis J, BLOEMER K, Weiss E, Ziegler A . Localization of the genes for tumor necrosis factor and lymphotoxin between the HLA class I and III regions by field inversion gel electrophoresis. Immunogenetics. 1988; 27(1):66-9. DOI: 10.1007/BF00404447. View

20.

Fugger L, Ryder L, Morling N, Odum N, Friis J, Pedersen F . DNA typing for HLA-DPB1*02 and -DPB1*04 in multiple sclerosis and juvenile rheumatoid arthritis. Immunogenetics. 1990; 32(3):150-6. DOI: 10.1007/BF02114968. View